One cycle of the chemotherapy regimen consist of a drip infusion of 1000mg/m2 of GEM weekly for 3 weeks and 1 week off, and this was repeated every 4 weeks. Patients receive hyperthermia once per week
Sponsors
Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine
Conditions
unresectable gallbladder cancerunresectable pancreatic cancer
Phase 2
A Phase II trial of combination therapy of gemcitabine and hyperthermia in unresectable pancreatic cancer.
Active, not recruitingJPRN-UMIN000001221
Start: 2008-06-01Target: 18Updated: 2026-06-29
A phase II trial of combination therapy of gemcitabine and hyperthermia in unresectable gallbladder cancer.
Active, not recruitingJPRN-UMIN000002824
Start: 2009-09-01Target: 30Updated: 2026-06-29